Unknown

Dataset Information

0

A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.


ABSTRACT: Glycans are cell-type-specific, posttranslational protein modifications that are modulated during developmental and disease processes. As such, glycoproteins are attractive biomarker candidates. Here, we describe a mass spectrometry-based workflow that incorporates lectin affinity chromatography to enrich for proteins that carry specific glycan structures. As increases in sialylation and fucosylation are prominent among cancer-associated modifications, we focused on Sambucus nigra agglutinin (SNA) and Aleuria aurantia lectin (AAL), lectins which bind sialic acid- and fucose-containing structures, respectively. Fucosylated and sialylated glycopeptides from human lactoferrin served as positive controls, and high-mannose structures from yeast invertase served as negative controls. The standards were spiked into Multiple Affinity Removal System (MARS) 14-depleted, trypsin-digested human plasma from healthy donors. Samples were loaded onto lectin columns, separated by HPLC into flow-through and bound fractions, and treated with peptide: N-glycosidase F to remove N-linked glycans. The deglycosylated peptide fractions were interrogated by ESI HPLC-MS/MS. We identified a total of 122 human plasma glycoproteins containing 247 unique glycosites. Importantly, several of the observed glycoproteins (e.g., cadherin 5 and neutrophil gelatinase-associated lipocalin) typically circulate in plasma at low nanogram per milliliter levels. Together, these results provide mass spectrometry-based evidence of the utility of incorporating lectin-separation platforms into cancer biomarker discovery pipelines.

SUBMITTER: Drake PM 

PROVIDER: S-EPMC3205961 | biostudies-literature | 2011 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.

Drake Penelope M PM   Schilling Birgit B   Niles Richard K RK   Braten Miles M   Johansen Eric E   Liu Haichuan H   Lerch Michael M   Sorensen Dylan J DJ   Li Bensheng B   Allen Simon S   Hall Steven C SC   Witkowska H Ewa HE   Regnier Fred E FE   Gibson Bradford W BW   Fisher Susan J SJ  

Analytical biochemistry 20100810 1


Glycans are cell-type-specific, posttranslational protein modifications that are modulated during developmental and disease processes. As such, glycoproteins are attractive biomarker candidates. Here, we describe a mass spectrometry-based workflow that incorporates lectin affinity chromatography to enrich for proteins that carry specific glycan structures. As increases in sialylation and fucosylation are prominent among cancer-associated modifications, we focused on Sambucus nigra agglutinin (SN  ...[more]

Similar Datasets

| S-EPMC6102642 | biostudies-literature
| S-EPMC1186948 | biostudies-other
| S-EPMC5597514 | biostudies-literature
| S-EPMC3745830 | biostudies-literature
| S-EPMC4038695 | biostudies-literature
| S-EPMC6366424 | biostudies-literature
| S-EPMC2546503 | biostudies-literature
| S-EPMC3531799 | biostudies-literature
| PRJNA844483 | ENA
| S-EPMC2792741 | biostudies-literature